Sole Source Purchase of Amniotic Membrane and Umbilical Cord Tissue Products for UNM Hospital

This contract represents a sole‑source acquisition by the University of New Mexico Hospital for specialized biologic graft materials used in ocular surgery. The vendor, Bio‑Tissue, Inc., will supply two cryopreserved products—AmnioGraft (amniotic‑membrane matrix) and AmnioGuard (umbilical‑cord and amniotic‑membrane matrix)—to support anti‑inflammatory, anti‑scarring, and anti‑angiogenic needs on the ocular surface. The purchase is valued at $100,000 for a one‑year period, with the possibility of renewal. Key points include: • Scope: Cryopreserved amniotic‑membrane and umbilical‑cord tissue grafts for ocular surface reconstruction and support. • Justification: Unique proprietary CryoTek cryopreservation technology deemed essential, leading to a sole‑source justification. • Term: Effective 06/04/2026 through 06/24/2027, with potential annual renewals.